Final Thoughts on Shingles Management
An expert emphasizes the importance of prompt antiviral treatment and personalized pain management for shingles—particularly in high-risk patients—while highlighting the…
Challenges in Shingles Prevention
An expert highlights the critical role of vaccination in preventing shingles—especially for high-risk patients with chronic conditions—while addressing challenges like…
A Silent Killer: Unmasking Radon’s Link to Lung Cancer
Experts discuss
Expert: Pharmacists Key to Improving Access to Zongertinib, Managing Side Effects
Joshua K. Sabari, MD, highlights pharmacists’ roles in coordinating access, financial assistance, and early side effect management for patients starting…
Advancing Precision Immunotherapy in Triple-Negative Breast Cancer Through Plasma Proteomics
Plasma proteomics revolutionizes treatment for triple-negative breast cancer, offering predictive insights and new therapeutic strategies through the innovative PIPscore.
Expert: Zongertinib Offers Well-Tolerated, Convenient Oral Option for HER2-Mutant NSCLC
Joshua K. Sabari, MD, explains zongertinib’s (Hernexeos) favorable safety profile and quality-of-life benefits over intravenous antibody-drug conjugates in patients with…
NCPA Leads Huge Coalition in Letter Asking Congress to Pass PBM Reform Act
Time to pass bipartisan measures, say 134 groups.
Shifting Federal COVID-19 Vaccine Guidance May Create Barriers to Access
Elizabeth Vaughan, MD, MPH, RD, addresses how state-level differences and potential new prescription requirements could impact patient access to COVID-19…
Tailoring Myelofibrosis Treatment Through JAK Inhibitors
Jessica Lewis-Gonzalez, PharmD, BCOP, discusses the challenges of managing myelofibrosis, from its heterogeneity and symptom burden to limited curative options.
What Pharmacists Should Know as Chagas Disease Circulates in the US
Health officials warn of rising Chagas disease cases in the US, linked to kissing bugs and the parasite Trypanosoma cruzi,…